Herschel S. Nachlis
Research Assistant Professor of GovernmentPolicy Fellow, Rockefeller Center for Public Policy
Herschel Nachlis is a Research Assistant Professor in the Department of Government and a Policy Fellow in the Nelson A. Rockefeller Center for Public Policy and the Social Sciences at Dartmouth.
He received his Ph.D. and M.A. in Politics and Social Policy from Princeton University, and B.A. in Political Science from Macalester College.
He studies and teaches American politics and public law, focusing on health and social policy and political institutions. His research examines health regulatory policy, mental health politics and policy, and the political development of public health and biomedical research programs. His research interests include the politics of public health and illness more generally, agencies and regulation, representation and inequality, judicial policymaking, and American political and Constitutional development.
His work has been published in journals including JAMA: The Journal of the American Medical Association and Studies in American Political Development and has been published in public outlets including STAT and The Washington Post, and his media commentary on public health has appeared in outlets including Nature, Vox, and Kaiser Health News.
He has been an Academic Visitor at Nuffield College, Univeristy of Oxford, his research has received the Robert C. Wood Paper Prize from the New England Political Science Association, and his teaching has received the George Kateb Prize from Princeton's Department of Politics. Previously, he was an Assistant Professor of Government at Franklin & Marshall College and a Postdoctoral Fellow in Dartmouth's Rockefeller Center for Public Policy.
Selected Publications
"Watch this FDA hearing on Thursday. It'll help ease your Covid-19 anxieties," STAT, October 21, 2020.
"The FDA's Evolving COVID-19 Emergency Use Authorizations: How The Convalescent Plasma Authorization Can Inform Future Vaccine and Therapeutic EUAs," Health Affairs Blog, October 20, 2020, DOI: 10.1377/hblog20201016.659416.
"Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval," JAMA: The Journal of the American Medical Association 324, no. 13 (2020): 1282-1283 (with Kyle Thomson).
"Crisis Governance, COVID-19, and American Policy History," Clio 29, no. 2 (2020): 6, 19-24.
"This is why the federal government has a hard time regulating prescription opioids," The Washington Post / Monkey Cage, January 13, 2019.
"Pockets of Weakness in Strong Institutions: Post-Marketing Regulation, Psychopharmaceutical Drugs, and Medical Autonomy, 1938-1982," Studies in American Political Development 32, no. 2 (2018): 257-291.
Review of David Vogel, The Politics of Precaution: Regulating Health, Safety, and Environmental Risks in Europe and the United States (Princeton: Princeton University Press, 2012), Law and Politics Book Review 23, no. 3 (2014): 135-140.